Michael Allen Jerman
Director, MIRA PHARMACEUTICALS, INC.
Companies
- ZIOPHARM OncologyBoard member Jul 17, 2025 to now1
- Inhibitor Therapeutics, Inc.Board member May 16, 2024 to now2
- Telomir Pharmaceuticals, Inc.Board member Feb 8, 2024 to Aug 29, 20243
- MIRA PHARMACEUTICALS, INC.Board member Nov 20, 2023 to Mar 27, 20244
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ZIOPHARM Oncology TCRT23,759 shares5$51.8K at $2.18Jul 23, 2026
- Inhibitor Therapeutics, Inc. INTI180,411 shares6$17.7K at $0.10May 4, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 23, 2026Granted 8,138 shares at $1.92 of ZIOPHARM Oncology5
- May 4, 2026Granted 50,000 shares of Inhibitor Therapeutics, Inc.6
- Apr 29, 2026Granted 6,032 shares at $2.59 of ZIOPHARM Oncology7
- Jan 12, 2026Granted 5,406 shares at $2.89 of ZIOPHARM Oncology8
- Nov 21, 2025Granted 4,183 shares at $3.16 of ZIOPHARM Oncology9
- Apr 1, 2025Granted 50,000 shares of Inhibitor Therapeutics, Inc.10
- Apr 1, 2024Granted 50,000 shares of Inhibitor Therapeutics, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZIOPHARM Oncology, Board member
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed May 1, 2026
- 8SEC EDGARForm 4 filed Jan 15, 2026
- 9SEC EDGARForm 4 filed Nov 26, 2025
- 10SEC EDGARForm 4 filed Apr 7, 2025
- 11SEC EDGARForm 4 filed May 16, 2024